Mid-term Data Collection of the Treatment of Intracranial Aneurysms With the WEB™ Aneurysm Embolization System

Ruptured and Unruptured Intracranial Aneurysms Clinical Trial

Official title: Data Collection of the Treatment of Intracranial Aneurysms With the WEB™ Aneurysm Embolization System: a Monocentric Post-market Observational Study

Status Withdrawn

Clinical Trial Summary

Flow disruption is a new endovascular approach for treatment of both ruptured and unruptured intracranial aneurysms, which involves placement of an endosaccular device (WEB) which modifies the blood flow at the level of the neck and induces intraaneurysmal thrombosis. The WEB was designed to treat wide-neck bifurcation aneurysms. This observational study will collect data about the routine practice in one center of using the WEB in ruptured and unruptured intracranial aneurysms. The primary objective is to evaluate its efficacy by assessing the anatomic outcome during follow-up.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Aneurysm
• Intracranial Aneurysm
• Ruptured and Unruptured Intracranial Aneurysms

• NCT number: NCT03379714
• Study type: Observational [Patient Registry]
• Source: Medical Therapy Solutions
• Status: Withdrawn
• Start date: January 1, 2018
• Completion date: January 31, 2022